GENENTECH INC.

In News

Genentech ends Xencor (NASDAQ: XNCR) efbalropendekin alfa license deal - Stock Titan

Stock Titan - Mar 09, 2026

Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform - Ventus Therapeutics

Ventus Therapeutics - Oct 21, 2025

How Genentech uncovered an alleged scheme to ship an expensive drug into the U.S. from Canada - The Business Journals

The Business Journals - Mar 02, 2026

Genentech Says Biocon Importing Infringing Cancer Drugs - Law360

Law360 - Mar 03, 2026

Roche's Genentech more than doubles investment in North Carolina facility to about $2 billion - Reuters

Reuters - Jan 20, 2026

Drugmaker Genentech supersizing investment, hiring plans in the Triangle - WRAL

WRAL - Jan 20, 2026

Biotech company Genentech is doubling its investment into Holly Springs - Axios

Axios - Jan 20, 2026

Andrew Chan Talks Transformative Medicines Nov. 17 - Research Horizons

Research Horizons - Oct 31, 2025

Genentech inks US$400m IBD deal with OMass Therapeutics - European Biotechnology Magazine

European Biotechnology Magazine - Sep 02, 2025

Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year - BioSpace

BioSpace - Oct 29, 2025

Biogen told to pay $124M in patent dispute with Genentech - Fierce Pharma

Fierce Pharma - Oct 06, 2025

Genentech and Roche Expand US Footprint with New North Carolina Manufacturing Facility - PharmTech.com

PharmTech.com - May 13, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment